Skip to content

Clinical trials

Terminated Breast Neoplasms trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Status: Terminated Country / region: Canada Clear all

80 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20022
20043
20051
20064
20073
20087
20093
20107
20112
20124
20131
20144
20154
20162
20178
20184
20195
20205
20212
20222
20233
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated80

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AHS Cancer Control Alberta8
Pfizer7
Hoffmann-La Roche5
University Health Network, Toronto5
Novartis Pharmaceuticals4
AstraZeneca2
Elevation Oncology2
GlaxoSmithKline2
National Cancer Institute (NCI)2
Odonate Therapeutics, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms80
Neoplasm Metastasis11
Ovarian Neoplasms7
Lung Neoplasms6
Carcinoma, Non-Small-Cell Lung5
Colorectal Neoplasms5
Melanoma5
Prostatic Neoplasms5
Triple Negative Breast Neoplasms5
Neoplasms4

Trials

Showing 1 to 25 of 80. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.